The ATP binding cassette transporter A1 contributes to the secretion of interleukin 1β from macrophages but not from monocytes

Biochemical and Biophysical Research Communications

Volumn 291, Issue 3, 2002, Pages 598-604

  Zhou, Xiaoqin ^a   Engel, Thomas ^a   Goepfert, Christian ^a   Erren, Michael ^a   Assmann, Gerd ^a   von Eckardstein, Arnold ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cytokines; Molecular biology; Monocytes and macrophages

Indexed keywords

ABC TRANSPORTER; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RELEASE; FOAM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRECURSOR; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION; TANGIER DISEASE;

EID: 0036298988     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2002.6473     Document Type: Article

References (41)

1. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist
2. Macrophage and monocyte IL-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing
3. Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14
4. Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells
5. Identification of a monocyte specific pre-interleukin 1 beta convertase activity
6. Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells
7. Interleukin-18 and interleukin-1 beta: Two cytokine substrates for ICE (caspase-1)
8. Interleukin-1 beta secretion. A possible multistep process that is regulated in a cell type-specific manner
9. IL-1 beta is secreted by activated murine macrophages as biologically inactive precursor
10. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor
11. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles
12. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence
13. Interleukin 1 is processed and released during apoptosis
14. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity
15. Interleukin 1β secretion is impaired by inhibitors of the ATP binding cassette transporter ABC1
16. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes
17. HDL and coronary heart disease: Role of cholesterol efflux and reverse cholesterol transport
18. Structure, function and regulation of the ABC1 gene product
19. Mutations in ABCA1 in Tangier disease and familial high density lipoprotein deficiency
20. The gene encoding ATP binding cassette transporter 1 is mutated in Tangier disease
21. Tangier disease is caused by mutations in the gene encoding ATP binding cassette transporter 1
22. Familial high density lipoprotein deficiency: Tangier disease
23. Plasmas and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I
24. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients
25. Phenotype-dependent differences in apolipoprotein E metabolism and cholesterol homeostasis in human monocyte-derived macrophages
26. Fluorescence flow cytometry of human leukocytes in the detection of LDL receptor defects in the differential diagnosis of hypercholesterolemia
27. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters
28. The Tangier disease gene product controls the cellular apolipoprotein-mediated lipid removal pathway
29. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages
30. Human ATP-binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred
31. A novel form of TNF/cachectin is a cell surface cytotoxic trans-membrane protein: Ramifications for the complex physiology of TNF
32. Post-translational modifications of human interleukin-6
33. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta
34. Proteasome-mediated regulation of interleukin-1beta turnover and export in human monocytes
35. Good cholesterol news
36. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins
37. Cellular localization trafficking of the human ABCA1 transporter
38. Cholesterol efflux to apolipoprotein A-I involves endocytosis and resecretion in a calcium-dependent pathway
39. Tangier disease: A disorder of intracellular membrane traffic
40. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease. Patients and Abc1-deficient mice
41. The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy